{
  "ticker": "JNJ",
  "target_date": "2025-01-08",
  "actual_date": "2025-01-08",
  "collected_at": "2025-12-08T11:15:03.141926",
  "price": {
    "open": 141.17,
    "high": 141.27,
    "low": 137.24,
    "close": 138.04437255859375,
    "volume": 11175600,
    "change_1d_pct": -2.71,
    "change_7d_pct": -1.92,
    "change_30d_pct": -7.58
  },
  "technicals": {
    "rsi_14": 37.62,
    "sma_20": 140.78,
    "sma_50": 146.12,
    "macd": -1.923,
    "macd_signal": -2.141,
    "macd_histogram": 0.218,
    "bb_upper": 143.82,
    "bb_lower": 137.74,
    "price_vs_sma20_pct": -1.95,
    "price_vs_sma50_pct": -5.53,
    "volume_ratio": 1.34
  },
  "fundamentals": {
    "market_cap": 488725512192,
    "pe_ratio": 19.580116,
    "forward_pe": 19.136793,
    "price_to_book": 6.1568584,
    "price_to_sales": 5.303644,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.39,
    "pct_from_52w_low": 44.19
  },
  "macro": {
    "spy": {
      "price": 584.37,
      "change_1d_pct": 0.15,
      "change_7d_pct": 0.22
    },
    "vix": {
      "level": 17.7,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.69
    },
    "dollar_index": {
      "level": 109.09
    },
    "gold": {
      "price": 2664.5
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson Temporarily Pulls New Treatment for Atrial Fibrillation to Probe Adverse Events",
      "source": "Yahoo",
      "datetime": 1736369879,
      "summary": "Johnson & Johnson (JNJ) Wednesday said it paused the rollout of Varipulse cardiac device in the US e",
      "url": "https://finnhub.io/api/news?id=91dd8781c142731413984bbb892e96bfa47a353f2d0ffe716469362cc54cc4b2"
    },
    {
      "headline": "J&J Falls \u2014 While Boston Scientific, Medtronic Pop \u2014 After Strokes Sideline A Key Product",
      "source": "Yahoo",
      "datetime": 1736361887,
      "summary": "Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.",
      "url": "https://finnhub.io/api/news?id=281f66352bc2508bc1d0f78680b30e0a197a098504556f9cd1500a74899969b6"
    },
    {
      "headline": "San Francisco Police Cancel Time Off as Healthcare Execs Descend",
      "source": "MarketWatch",
      "datetime": 1736357340,
      "summary": "San Francisco Police Cancel Time Off as Healthcare Execs Descend",
      "url": "https://finnhub.io/api/news?id=d4f134b550c3a8c60863a258cf152f37c683e7cc5e0cfc0352b9f34193782df9"
    },
    {
      "headline": "J&J pauses Varipulse PFA cases in US",
      "source": "Yahoo",
      "datetime": 1736350453,
      "summary": "The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for the pulsed field ablation system.",
      "url": "https://finnhub.io/api/news?id=91fdcba77d87dc71506b99b6b18cf06cf93cc0e3c912c3c3fc2a2d390851f5c6"
    },
    {
      "headline": "Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset",
      "source": "SeekingAlpha",
      "datetime": 1736344771,
      "summary": "Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.",
      "url": "https://finnhub.io/api/news?id=87d0d384d748ad6d1bf599c10bc381505dc40cf6f51ed49e2b62d2fe67b84efb"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}